Pseudomonas infection: exotoxin A effect

Bibliography:
1. Ilyukevich GV. Pseudomonas aeruginosa infection: New century with the problem researched. Medical news 2004; (12): 3-8
2. Rudnov VA. Modern clinical view on Pseudomonas aeruginosa infection and possibilities of the therapy in patients of resuscitation departments. Infections and antimicrobial therapy 2002; 4 (6): 32-40
3. Rudnov VA, Belsky DV, Dekhnich FV, Research group of resuscitation department. Infections at Resuscitation departments in Russia: results of national multicentral research. Clinical microbiology and microbial chemotherapy 2011; 13 (4): 294-303
4. Driscoll JA, Brody SL, Kollef MH. The epidemiology pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 2007; 67 (3): 351-368
5. Vincent JL, Rello J, Marshall J, et al. EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302 (21): 2323-2329
6. Ratjen F, Doring G, and Nikolaizik WH. Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis. Lancet 2001; 358 (9286): 983-984
7. Wu DC, Chan WW, Metelitsa Al, et al. Pseudomonas skin infection clinical features, epidemiology, and management. Am J Clin Dermatol2011; 12: 157-169. 8. Moroz AF, Antsiferova NG, Baskakova NV Pseudomonas aeruginosa infection. M.: Medicine, 1988: 256 p.)
9. Brook I, Frazier EH, Yeager JK. Microbiology of infected poison ivy dermatitis. Br J Dermatol 2000; 142 (5): 943-946
10. Petropoulou H, Giamarellos-Bourboulis EJ, Kavatzas N, et al. Early cutaneous alterations in experimental sepsis by Pseudomonas aeruginosa. Dermatology 2004; 209 (2): 111-116
11. SimonettiA, Ottaiano E, Diana MV, etal. Epidemiology of hospital-acquired infections in an adult intensive care unit: results of a prospective cohort study. Ann Ig 2013; 25 (4): 281-289
12. Reshedko GK, Ryabkova EL, Krechnikova 01. Resistency to antibiotics of gram-negative agents of nosocomial infections at resuscitation department in general hospitals of Russia. Clinical microbiology and microbial chemotherapy. 2008; (10): 96-112
13. Sun С, Zhou Y, Chai W, Wang Y. Analysis of microbiology and antibiotic susceptibility in 131 cases of prosthetic hip infections. Zhonghua Yi Xue Za Zhi 2014; 94 (21): 1657-1660
14. Lv L, Jiang T, Zhang S, Yu X. Exposure to mutagenic disinfection byproducts leads to increase of antibiotic resistance in Pseudomonas aeruginosa. Environ Sci Technol 2014; 48 (14): 8188-8195
15. Osmon S, Ward S, Fraser VJ, Kollef MH. Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa. Chest 2004; 125 (2): 607-616
16. Goldberg JB, Hancock REW, Parales RE, Loper J, and Cornells P. Pseudomonas 2007. J Bacteriol 2008; 190 (8): 2649-2662
17. Supotnitsky MV. Microorganisms, toxins and epidemics. M.: Higher school text-book, 2010; 376 p.
18. Shimada Т, Matsumura I. Immune evasion of Pseudomonas aeruginosa. Nihon Rinsho Meneki Gakkai Kaishi 2014; 37(1): 33-41
19. Vertiev YuV, Brodinova NS, Moroz AF. Exotoxin A Pseudomonas aeruginosa and its role in the pathogenesis of Pseudomonas aeruginosa infection. Zh Mikrobiol Epidemiol Immunobiol 1981; (2): 13-19
20. Miyazaki S, Matsumoto Т, Tateda К, et al. Role of exotoxin A in inducing severe Pseudomonas aeruginosa infections in mice. J Med Microbiol 1995; 43 (3): 169-175
21. Nikbin VS, Aslani MM, Sharafi Z, et al. Molecular identification and detection of virulence genes among Pseudomonas aeruginosa isolated from different infectious origins. Iran J Microbiol 2012; 4(3): 118-123
22. Woods DE, Cryz SJ, Friedman RL, Iglewski BH. Contribution oftoxinAand elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats. Infect Immun. 1982; 36(3): 1223-1228
23. El-Zaim HS, Chopra AK, Peterson JW, et al. Protection against exotoxin A (ETA) and Pseudomonas aeruginosa infection in mice with ETA-specific antipeptide antibodies. Infect Immun 1998; 66 (11): 5551-5554
24. Ezepchuk JuV Pathogenicity as a function of biomolecules. M., 1985; 238 p.
26. Deng Q, Barbieri JT Molecular mechanisms of the cytotoxicity of ADP-ribosylating toxins. Annu Rev Microbiol 2008; 62:271-288). 27. Jger D, Werdan K, Mbller-Werdan U. Endogenous ADP-ribosylation of elongation factor-2 by interleukin-1 p. Mol Cell Biochem 2011; 348 (1-2): 125-128
28. Tafesse FG, Guimaraes CP, Maruyama T, et al. GPR107, a G-protein-coupled Receptor Essential for Intoxication by Pseudomonas aeruginosa Exotoxin A, Localizes to the Golgi and Is Cleaved by Furin. J Biol Chem 2014; 289 (35): 24005-24018
29. Mrsny RJ, Daugherty AL, McKee ML, FitzGerald DJ. Bacterial toxins as tools for mucosal vaccination. Drug Discov Today 2002; 7 (4); 247-258
30. Hansen JK, Forest KT. Type IV pilin structures: insights on shared architecture, fiber assembly, receptor binding and type II secretion. J Mol Microbiol Biotechnol 2006; 11 (3-5): 192-207
31. Jorgensen R, Merrill AR, Andersen GR. The life and death of translation elongation factor 2. Biochem Soc Trans 2006; 34(1): 1-6
32. Davinic M, Carty NL, Colmer-Hamood JA, et al. Role of Vfr in regulating exotoxin A production by Pseudomonas aeruginosa. Microbiology 2009; 155 (7): 2265-2273
33. Chiu CC, Chen HH, Chuang HL, et al. Pseudomonas aeruginosa exotoxin A-induced hepatotoxicity: an animal model in rats. J Vet Med Sci 2009; 71 (1): 1-8
34. Zhao GJ, Hong GL, Liu JQ, et al. Septic shock due to community-acquired Pseudomonas aeruginosa necrotizing fasciitis: A case report and literature review. Exp Ther Med 2014; 7(6): 1545-1548
35. Bard F, Mazelin L, Pechoux-Longin C, et al. Src regulates Golgi structure and KDEL receptor-dependent retrograde transport to the endoplasmic reticulum. J Biol Chem 2003; 278 (47): 46601-46606
36. Borkar DS, Fleiszig SM, Leong C, et al. Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis. JAMA Ophthalmol 2013; 131 (2): 147-153
37. Somerville G, Mikoryak CA, Reitzer L. Physiological characterization of Pseudomonas aeruginosa during exotoxin A synthesis: glutamate, iron limitation, and aconitase activity. J Bacteriology 1999; 181 (4): 1072-1078
38. Ben Haj Khalifa A, Moissenet D, Vu Thien H, et al. Virulence factors in Pseudomonas aeruginosa: mechanisms and modes of regulation. Ann Biol Clin (Paris) 2011; 69 (4): 393-403
39. Denis-Mize KS, Price BM, Baker NR, et al. Analysis of immunization with DNA encoding Pseudomonas aeruginosa exotoxin A. FEMS Immunol Med Microbiol 2000; 27 (2): 147-154
40. Manafi A, Kohanteb J, Mehrabani D, et al. Active immunization using exotoxin A confers protection against Pseudomonas aeruginosa infection in a mouse burn model. ВМС Microbiol 2009; 9 (23). http://www.ncbi.nlm.nih.gov/ pubmed/19183501
41. Schumann J, Angermbller S, Bang R, et al. Acute hepatotoxicity of Pseudomonas aeruginosa exotoxin A in mice depends on T cells and TNF. J Immunol 1998; 161 (10): 5745-5754
42. Jenkins CE, Swiatoniowski A, Issekutz AC, Lin TJ. Pseudomonas aeruginosa exotoxin A induces human mast cell apoptosis by a caspase-8 and -3-dependent mechanism. J Biol Chem 2004; 279 (35): 37201-37207
43. Chiu CC, Huang YT, Wang YC, et al. Pretreatment with lipopolysaccharide ameliorates PseudomonasexotoxinA-induced hepatotoxicity in rats. Immunopharmacol Immunotoxicol 2013; 35 (2): 296-303
44. Morrison VV, Morrison AV Qualitative and quantitative changes of cellular composition of peripheral blood in experimental animals effected by Pseudomonas aeruginosa exotoxin. Fundamental research 2008; (4): 19-25
45. Morrison VV, Morrison AV. Immunologic effects of Pseudomonas aeruginosa exotoxin A on white rats. In: Actual problems of medical science and education. Saratov, 2009; p. 178-179
46. Morrison VV, Morrison AV. Immunologic effects of Pseudomonas aeruginosa exotoxin A. In: Actual problems of infectious pathology and vaccine prophylaxis in children. Saratov, 2009; p. 93-94
47. Morrison VV, Morrison AV. The evaluation of protective properties of immunomodulator of diutifon and antioxidant mexidol in Pseudomonas aeruginosa exotoxin. In: Questions on pathogenesis of typical pathological processes. Novosibirsk, 2012; p. 192-194
48. Morrison VV, KudinGB, Nefedova NA. The process of lipid peroxidation and antioxidant system in dynamics of experimental Pseudomonas aeruginosa intoxication. Anesthesiology and Reanimatology 2000; (3): 41-43
49. Morrison VV, Morrison AV. Changes in lipid peroxidation and antioxidant system in dynamics of experimental Pseudomonas aeruginosa intoxication. In: Oxygen and antioxidants. Volgograd, 2009; (1): p. 91-92
50. Morrison VV, Morrison AV Procalcitonin as an indicator of severity of experimental Pseudomonas aeruginosa intoxication. In: Actual problems of pathological physiology. Saratov, 2011; p. 221-224)
51. Sandoval CC, Moreno МС, Abarca VK. Sepsis due to Pseudomonas aeruginosa in a previously healthy infant. Rev Chilena Infectol 2011; 28 (6): 592-596
52. Erol S, Zenciroglu A, Dilli D, et al. Evaluation of nosocomial blood stream infections caused by Pseudomonas species in newborns. Clin Lab 2014; 60 (4): 615-620.